Repro-Med Systems Inc. is engaged in the design and manufacture of medical devices directing resources to the global markets for emergency medical products and infusion therapy.
| Revenue (Most Recent Fiscal Year) | $28.52M |
| Net Income (Most Recent Fiscal Year) | $-13.74M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 3.51 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 5.38 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -29.75% |
| Net Margin (Trailing 12 Months) | -45.24% |
| Return on Equity (Trailing 12 Months) | -25.10% |
| Return on Assets (Trailing 12 Months) | -18.73% |
| Current Ratio (Most Recent Fiscal Quarter) | 4.01 |
| Quick Ratio (Most Recent Fiscal Quarter) | 3.37 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.02 |
| Inventory Turnover (Trailing 12 Months) | 2.81 |
| Book Value per Share (Most Recent Fiscal Quarter) | $0.42 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.02 |
| Earnings per Share (Most Recent Fiscal Year) | $-0.13 |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.28 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Common Shares Outstanding | 45.76M |
| Free Float | 34.05M |
| Market Capitalization | $102.97M |
| Average Volume (Last 20 Days) | 0.14M |
| Beta (Past 60 Months) | 0.55 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 25.60% |
| Percentage Held By Institutions (Latest 13F Reports) | 58.60% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |